Biopol Chemicals IPO 2026: GMP, Price Band, Financials and Allotment Timeline

The initial public offering (IPO) of Biopol Chemicals, a manufacturer of speciality chemicals, will open for public subscription on Friday, February 6, 2026. Through its maiden share sale, the company aims to raise ₹31.26 crore, entirely through a fresh issue of 2.9 million equity shares.

The issue will be listed on the NSE SME platform, making it one of the notable SME IPOs scheduled for February 2026.

Biopol Chemicals IPO: Price Band and Lot Size

IPO pricing details

• Price band: ₹102 to ₹108 per share

• Lot size: 1,200 equity shares

At the upper price band of ₹108, a retail investor bidding for two lots (2,400 shares) will need to invest ₹2,59,200.

About Biopol Chemicals: Business Overview

Biopol Chemicals operates in the trading, manufacturing and distribution of speciality chemicals, serving multiple industrial segments through a business-to-business (B2B) model.

Product portfolio

The company offers 66 products across four key categories:

• 40 silicone-based products

• 5 emulsifier-based products

• 15 biochemical products

• 6 polyelectrolyte products

End-user industries

Biopol caters to a wide range of sectors, including:

• Textiles

• Home care

• Agriculture

• Industrial chemicals

Manufacturing Facilities and Presence

Biopol Chemicals operates through four establishments located in Gujarat and West Bengal, which include:

• Manufacturing unit

• Corporate office and warehouse in West Bengal

• Registered office in Gujarat

This geographic presence supports its production, logistics and distribution requirements.

Biopol Chemicals IPO Key Dates

Important IPO timeline

• IPO opens: Friday, February 6, 2026

• IPO closes: Tuesday, February 10, 2026

• Basis of allotment: Wednesday, February 11, 2026

• Shares credited to demat: Thursday, February 12, 2026

• Listing on NSE SME: Friday, February 13, 2026

Biopol Chemicals IPO: Registrar and Lead Manager

• Registrar: Bigshare Services

• Book-running lead manager: Smart Horizon Capital Advisors

Biopol Chemicals IPO Objectives

Use of proceeds

As per the red herring prospectus (RHP), the company plans to utilise the net fresh issue proceeds as follows:

• ₹12.26 crore for the acquisition of industrial land

• ₹11.10 crore for repayment or prepayment of certain borrowings

• Remaining funds for general corporate purposes

Biopol Chemicals Financial Performance

Revenue and profitability trend

• FY25 revenue from operations: ₹49.12 crore

• FY24 revenue: ₹25.46 crore

This marks a near-doubling of revenue year-on-year.

Earnings growth

• FY25 EBITDA: ₹6.53 crore

• FY24 EBITDA: ₹4.42 crore

• EBITDA growth: 47.5%

Profit after tax

• FY25 PAT: ₹4.33 crore

• FY24 PAT: ₹2.96 crore

The steady improvement in revenue and profitability highlights the company’s operational growth ahead of its public listing.

What Investors Should Watch

With exposure to the speciality chemicals segment, a diversified product portfolio, and improving financial metrics, the Biopol Chemicals IPO will be closely tracked by SME investors. However, as with all SME IPOs, investors should also consider liquidity, business scalability, and sector-specific risks before subscribing.

Disclaimer:

The information provided in this article on ThinkWithNiche is for informational and educational purposes only and should not be construed as investment advice, financial advice, or a recommendation to buy, sell, or hold any securities. All data, figures, and details are based on publicly available information and company disclosures at the time of writing and are believed to be accurate; however, ThinkWithNiche does not guarantee the completeness, accuracy, or reliability of the information.

Investing in initial public offerings (IPOs), especially SME IPOs, involves market risks, including the risk of loss of capital. Readers are advised to conduct their own research and due diligence and consult with a qualified financial advisor or registered investment professional before making any investment decisions. ThinkWithNiche, its authors, and affiliates shall not be held responsible for any financial losses or decisions taken based on the information presented in this article.